22-07-2020
phonlamaiphoto / iStockphoto.com
Artificial Intelligence (AI) offers exciting and unprecedented opportunities for life sciences and healthcare but also poses complex questions for the IP sector, as an LSPN Connect session discovered yesterday, July 21.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
LSPN Connect, Artificial Intelligence, patent, Ryan Abbott, AI, life sciences, John Sninsky, Nathan Zhang, patents, trade secrets, healthcare, inventor
EPO affirms that AI cannot invent
22-12-2021
Only humans can invent, says judge in first US AI patent decision
06-09-2021
AI security commission lambasts US over ‘failure’ to protect IP
03-03-2021
LSPN Connect: Intel, Lenovo share experiences of racism
17-09-2020
LSPN Connect: Exclusive interview with UKIPO CEO Tim Moss
15-07-2020
LSPN Connect: The Tech Access Partnership and COVID-19
01-07-2020
Five minutes with…John Sninsky
30-11--0001
